Helicobacter pylori eradication in patients with non-ulcer dyspepsiaXIA, H. H.-X; TALLEY, N. J.Drugs (Basel). 1999, Vol 58, Num 5, pp 785-792, issn 0012-6667Article

Helicobacter pylori infection, reflux esophagitis, and atrophic gastritis : An unexplored triangleXIA, H. H.-X; TALLEY, N. J.The American journal of gastroenterology. 1998, Vol 93, Num 3, pp 394-400, issn 0002-9270Article

Double-blind, randomized controlled study to assess the effects of lansoprazole 30 mg and lansoprazole 15 mg on 24-h oesophageal and intragastric pH in Chinese subjects with gastro-oesophageal reflux diseaseWONG, W. M; LAI, K. C; LAM, S. K et al.Alimentary pharmacology & therapeutics. 2004, Vol 19, Num 4, pp 455-462, issn 0269-2813, 8 p.Article

Metronidazole- and clarithromycin-resistant Helicobacter pylori in dyspeptic patients in western Sydney as determined by testing multiple isolates from different gastric sitesXIA, H. H.-X; KALANTAR, J; TALLEY, N. J et al.Journal of gastroenterology and hepatology. 1998, Vol 13, Num 10, pp 1044-1049, issn 0815-9319Article

Trends in the prevalence of peptic ulcer disease and Helicobacter pylori infection in family physician-referred uninvestigated dyspeptic patients in Hong KongXIA, B; XIA, H. H. X; WONG, B. C. Y et al.Alimentary pharmacology & therapeutics. 2005, Vol 22, Num 3, pp 243-249, issn 0269-2813, 7 p.Article

Twenty-minute 50 mg ¹³C-urea breath test without test meal for the diagnosis of Helicobacter pylori infection in ChineseWONG, W. M; WONG, B. C. Y; LI, T. M et al.Alimentary pharmacology & therapeutics. 2001, Vol 15, Num 9, pp 1499-1504, issn 0269-2813Article

Randomized controlled study of rabeprazole, levofloxacin and rifabutin triple therapy vs. quadruple therapy as second-line treatment for Helicobacter pylori infectionWONG, W. M; GU, Q; WONG, B. C. Y et al.Alimentary pharmacology & therapeutics. 2003, Vol 17, Num 4, pp 553-560, issn 0269-2813, 8 p.Article

An evaluation of a rapid urine test for the diagnosis of Helicobacter pylori infection in the Chinese populationWONG, W. M; WONG, B. C. Y; XIA, H. H. X et al.Alimentary pharmacology & therapeutics. 2002, Vol 16, Num 4, pp 813-817, issn 0269-2813Article

One-week omeprazole, furazolidone and amoxicillin rescue therapy after failure of Helicobacter pylori eradication with standard triple therapiesWONG, W. M; WONG, B. C. Y; LAM, S. K et al.Alimentary pharmacology & therapeutics. 2002, Vol 16, Num 4, pp 793-798, issn 0269-2813Article

Upper gastrointestinal evaluation of Chinese patients with non-cardiac chest painWONG, W.-M; LAI, K. C; LAU, C. P et al.Alimentary pharmacology & therapeutics. 2002, Vol 16, Num 3, pp 465-471, issn 0269-2813Article

Long-term prospective follow-up of endoscopic oesophagitis in southern Chinese: prevalence and spectrum of the diseaseWONG, W.-M; LAM, S. K; WONG, B. C. Y et al.Alimentary pharmacology & therapeutics. 2002, Vol 16, Num 12, pp 2037-2042, issn 0269-2813, 6 p.Article

Review article : 'true' re-infection of Helicobacter pylori after successful eradication -worldwide annual rates, risk factors and clinical implicationsZHANG, Y.-Y; XIA, H. H.-X; ZHUANG, Z.-H et al.Alimentary pharmacology & therapeutics. 2009, Vol 29, Num 2, pp 145-160, issn 0269-2813, 16 p.Article

Helicobacter pylori infection and non-ulcer dyspepsiaTALLEY, N. J; XIA, H. H.-X.British medical bulletin. 1998, Vol 54, Num 1, pp 63-69, issn 0007-1420Article

Can Helicobacter pylori serology still be applied as a surrogate marker to identify peptic ulcer disease in dyspepsia?XIA, H. H.-X; KALANTAR, J. S; MITCHELL, H. M et al.Alimentary pharmacology & therapeutics. 2000, Vol 14, Num 5, pp 615-624, issn 0269-2813Article

Antral-type mucosa in the gastric incisura, body, and fundus (antralization) : A link between Helicobacter pylori infection and intestinal metaplasia?XIA, H. H.-X; KALANTAR, J. S; TALLEY, N. J et al.The American journal of gastroenterology. 2000, Vol 95, Num 1, pp 114-121, issn 0002-9270Article

An evaluation of whole blood testing for Helicobacter pylori in general practiceTALLEY, N. J; LAMBERT, J. R; HOWELL, S et al.Alimentary pharmacology & therapeutics. 1998, Vol 12, Num 7, pp 641-645, issn 0269-2813Article

Clinical and endoscopic characteristics of non-Helicobacter pylori, non-NSAID duodenal ulcers: a long-term prospective studyXIA, H. H.-X; WONG, B. C. Y; WONG, K. W et al.Alimentary pharmacology & therapeutics. 2001, Vol 15, Num 12, pp 1875-1882, issn 0269-2813Article

Aberrant epithelial expression of trefoil family factor 2 and mucin 6 in Helicobacter pylori infected gastric antrum, incisura, and body and its association with antralisationXIA, H. H-X; YANG, Y; LAM, S. K et al.Journal of clinical pathology. 2004, Vol 57, Num 8, pp 861-866, issn 0021-9746, 6 p.Article

Optimal serological tests for the detection of Helicobacter pylori infection in the Chinese populationXIA, H. H.-X; WONG, B. C. Y; LAM, S. K et al.Alimentary pharmacology & therapeutics. 2002, Vol 16, Num 3, pp 521-526, issn 0269-2813Article

Effect of cyclo-oxygenase inhibitors on Helicobacter pylori susceptibility to metronidazole and clarithromycinGU, Q; XIA, H. H.-X; WONG, B. C.-Y et al.Alimentary pharmacology & therapeutics. 2004, Vol 20, Num 6, pp 675-681, issn 0269-2813, 7 p.Article